Empirical Micafungin Treatment and Survival Without Invasive Fungal Infection in Adults With ICU-Acquired Sepsis, Candida Colonization, and Multiple Organ FailureEmpirical Micafungin Treatment and Invasive Fungal Infection–Free Survival

Jean-François Timsit, MD, PhD summarizes results of his and coauthors’ randomized trial evaluating the effect of empiric treatment with micafungin on survival without invasive fungal infection among adults with ICU- acquired sepsis, Candida colonization at multiple sites, and multiple organ failure. Results were presented Wednesday, October 5th, 2016 at the European Society of Intensive Care Medicine’s LIVES 2016 Congress in Milan. Used with permission.